📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Walvax Biotechnology Co Ltd

Common Name
Walvax Biotechnology
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,388
Ticker
300142
Exchange
SHENZHEN STOCK EXCHANGE
Description
Walvax Biotechnology Co., Ltd. is a leading biopharmaceutical company based in China, focusing on the research, development, and commercialization of vaccines and biopharmaceutical products. Establish...

Walvax Biotechnology's Group Entities Data Preview

The Group Entity dataset is currently being compiled; join the waitlist to secure early access!

As of the end of fiscal year 2024, Tracenable has captured detailed data on Walvax Biotechnology's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group.a

The dataset includes information on 19 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Walvax Biotechnology's consolidated operations.a

Tracenable's data also records the effective ownership percentages that Walvax Biotechnology holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices.a

Entity NameCountryTypeOwnershipLEIPermID
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary78.26%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary56.62%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHNSubsidiary100%
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
Showing 12 out of 19 entities. Get complete coverage in the full dataset.
Download Data

Verified Sources Behind Walvax Biotechnology’s Group Entities Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Walvax Biotechnology’s data sources below and access millions more through our Disclosure Search.

a. Walvax Biotechnology's Annual Report 2024
a. Walvax Biotechnology's Annual Report 2024

Insights into Walvax Biotechnology's Group Entities Location

Tracenable's group entities dataset provides geographic insights into Walvax Biotechnology's significant subsidiaries, revealing their location around the world.a

In total, the Walvax Biotechnology group includes 19 significant subsidiaries distributed across 4 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure.a

This visualization highlights the geographical distribution of Walvax Biotechnology's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a

How geographically diverse is Walvax Biotechnology's corporate structure?

In 2024, Tracenable identified that the Walvax Biotechnology group consisted of19 significant subsidiaries, located across 4 countries.a

This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network.a

What does the geographic footprint of Walvax Biotechnology reveal about its business operations?

Walvax Biotechnology's significant subsidiaries are primarily located in Asia and North America, which together host 100% of its material entities.a

This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.

How transparent is Walvax Biotechnology about its group entities and ownership structure?

Walvax Biotechnology exhibits a limited level of transparency concerning its corporate ownership structure.

The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance.a

Without full group hierarchy or equity details, it offers a restricted view of Walvax Biotechnology's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.

Does Walvax Biotechnology maintain entities in low-tax or offshore jurisdictions?

Yes. Tracenable's data shows that 1 entities (5.26%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as British Virgin Islands.a

This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Walvax Biotechnology's ownership structure.